SCM
DGX icon

Sigma Capital Management’s Quest Diagnostics DGX Stock Holding History

Sigma Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-19,450
Closed -$1.2M – 186
2013
Q3 		$1.2M Sell
19,450
-10,550
-35% -$631K 0.05% 229
2013
Q2 		$1.82M Buy
+30,000
New +$1.79M 0.08% 186

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sigma Capital Management's DGX Position: Q4 2013 in Review

Sigma Capital Management sold out of Quest Diagnostics (DGX) in Q4 2013, closing a stake of 19,450 shares — an estimated $1.2M sold.

Sigma Capital Management first reported a position in DGX in Q2 2013 and held it in 2 quarters. The position peaked at $1.82M in Q2 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Sigma Capital Management reported no remaining Quest Diagnostics position as of Q4 2013 after selling out during the quarter.
  • Sigma Capital Management sold 19,450 Quest Diagnostics shares in Q4 2013, an estimated $1.2M.
  • Sigma Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 2 quarters.
  • Sigma Capital Management's Quest Diagnostics position peaked at $1.82M in Q2 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Sigma Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.